CSF Aβ42/Aβ40 is a Potential Predictor of AD Pathology in Comparison to Other Available Biomarkers
Claire Sweeney and Ian Murray, PhD Introduction. Alzheimer’s disease (AD) is a neurodegenerative disease in which tau and amyloid proteins misfold to form pathological neurofibrillary tangles and amyloid plaques.6 There are an estimated 50 million AD patients worldwide and this number is expected to triple by 2050 as the increasing…